The medical school will work with a drugmaker to sequence the viral genomes to explore host susceptibility, clinical outcomes of whole-genome sequencing, host-virus interactions, and disease severity.
from Section Page News - Modern Healthcare https://ift.tt/3csz9Gj
via IFTTT
No comments:
Post a Comment